Lifetime Risk of Cutaneous Melanoma in 185 Countries: Decomposing its Difference From Cumulative Risk into Methodological and Longevity Effects

Clicks: 204
ID: 325001
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #23 of 415 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 415 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
This study calculated lifetime risks of developing and dying from cutaneous melanoma across 185 countries, finding global rates of 0.49% and 0.10% respectively, with substantial variation by development index and geographic region. By decomposing the difference between lifetime and cumulative risk, the analysis reveals that risk accruing beyond age 74 years (rather than methodological adjustments) accounts for over 40% of the lifetime risk gap, indicating that lifetime risk is substantially higher than conventional cumulative risk estimates in long-lived populations. These findings support using lifetime risk as a complementary metric to cumulative risk when comparing melanoma burden across populations with differing life expectancy.
Reference Key
openalex_W7203460919 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag336
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.